edgepedia

Life and health

72,234 articles

Interferon alfacon-1

Interferon alfacon-1 (consensus interferon, Infergen) is a synthetic 166-amino-acid type I interferon alpha for chronic hepatitis C, FDA-approved 1997, withdrawn in the EU in 2006.

Interferon beta

Interferon beta (IFN-β), type I interferon; recombinant products Betaseron, Avonex, Rebif, Plegridy; first disease-modifying therapy for relapsing-remitting multiple sclerosis, FDA approved 1993, reducing relapses 15-36%.

Interferon beta-1a

Interferon beta-1a, sold as Avonex, Rebif, and pegylated Plegridy, is a glycosylated type I interferon drug for relapsing multiple sclerosis; FDA-approved from 1996, it reduces relapses about 30% versus placebo.

Interferon beta-1b

Interferon beta-1b (Betaseron, Betaferon, Extavia) is a recombinant, non-glycosylated 165-amino-acid type I interferon from E. coli, injected 250 µg every other day; the first FDA-approved MS disease-modifying therapy (1993).

Interferon gamma

Interferon gamma (IFN-γ, IFNG) is the sole type II interferon, a cytokine from T cells, NK cells, and ILC1s signaling through IFNGR1/IFNGR2, Jak1/Jak2, and STAT1; it activates macrophages, has direct antiviral mechanisms, and is the drug Actimmune and the basis of TB interferon-gamma release assays.

Interferon gamma release assay

The interferon gamma release assay, or IGRA, is a blood test that measures interferon-gamma released by T cells exposed to tuberculosis antigens, detecting infection, mainly latent tuberculosis, without BCG interference.

Interferon Signaling

Interferon signaling: how type I, II, and III interferons (IFN-α/β, IFN-γ, IFN-λ) signal through IFNAR, IFNGR, and IFNLR receptors via the JAK-STAT pathway to induce interferon-stimulated genes.

Interflora

Interflora: international flower delivery network relaying orders to local florists; British unit founded 30 May 1923, linked to Fleurop (1927) and FTD (1910); global group formed 1946 in Copenhagen; UK unit owned by Teleflora UK Holdings, based in Sleaford.

Interfollicle cell

Interfollicle cell, also called stalk follicle cell or stalk cell, is a Drosophila ovarian somatic cell in the 5-8 cell stalk connecting adjacent egg chambers, specified by Notch and JAK-STAT signaling and protected from excess apoptosis.

InterHeart study

The INTERHEART study was a case-control study of first heart attacks across 52 countries, finding that nine modifiable risk factors account for more than 90% of heart attack risk worldwide.

Interlaminar discectomy

Interlaminar discectomy is a spine operation removing herniated lumbar disc material through the natural gap between laminae, decompressing nerve roots to relieve sciatic leg pain.

Interleukin

Interleukins (ILs) are a family of immune-signaling cytokines; over 60 designated, 38 formally recognized (IL-1 to IL-38). Grouped into IL-1, common gamma-chain, and IL-6/IL-12 families; marked by pleiotropy and redundancy; targets of anakinra, tocilizumab, secukinumab.

Interleukin 2

Interleukin-2 (IL-2, T-cell growth factor, TCGF) is a 15.5 kDa cytokine discovered in 1976 by Gallo's team; high-dose aldesleukin treats metastatic renal cell carcinoma and melanoma, low-dose IL-2 expands Tregs for autoimmune disease.

Interleukin 6

Interleukin 6 (IL-6, BSF-2) is a pleiotropic pro-inflammatory cytokine signaling through IL-6R and gp130 via JAK/STAT3, driving acute-phase response, autoimmunity, cancer, and COVID-19 cytokine storm; targeted by tocilizumab.

Interleukin-1 alpha

Interleukin-1 alpha (IL-1α) is a pro-inflammatory cytokine and one of two forms of interleukin-1, produced chiefly by macrophages, encoded by the IL1A gene on chromosome 2.

Interleukin-1 family

Interleukin-1 family: eleven cytokines including IL-1α, IL-1β, IL-18, IL-33, IL-36, IL-37, IL-38 and IL-1Ra; innate immune agonists and antagonists activated via caspase-1 inflammasomes, targeted by anakinra, canakinumab, and rilonacept.

Interleukin-10

Interleukin-10 (IL-10, CSIF) is an anti-inflammatory cytokine of the IL-10 family signaling via IL-10R1/R2, JAK1/TYK2, and STAT3; deficiency causes colitis, and pegylated IL-10 (pegilodecakin) failed phase III pancreatic cancer trials.

Interleukin-11

IL11 (interleukin 11, AGIF) is a 178-amino-acid IL-6 family cytokine on chromosome 19q13.42 that signals via IL-11Rα and gp130 through JAK/STAT3 and ERK. Recombinant IL-11 (oprelvekin) treats chemotherapy-induced thrombocytopenia; IL-11 also drives fibrosis and cancer stroma.

Interleukin-12

Interleukin-12 (IL-12, NKSF) is a 70 kDa heterodimeric cytokine of p40 and p35 subunits, made by dendritic cells and macrophages, that drives Th1 immunity and IFN-γ production via JAK2/TYK2-STAT4 signaling and shares p40 with IL-23.

Interleukin-13

IL13 (interleukin-13, P600) is a human gene at 5q31.1 encoding a 13 kDa Th2 cytokine that signals via IL-4Rα/IL-13Rα1 and STAT6, drives asthma effector phase, and is targeted by lebrikizumab and dupilumab.

Interleukin-15

Interleukin-15 (IL-15), also called IL-T when first found in HuT-102 cells, is a 14-15 kDa common gamma-chain cytokine supporting NK and memory CD8 T cells; discovered in 1994, FDA-approved as nogapendekin alfa (Anktiva) in 2024.

Interleukin-16

IL16 (interleukin 16, lymphocyte chemoattractant factor) is a cytokine gene at 15q26.3 whose caspase-3-cleaved product chemoattracts CD4+ cells via CD4, primes TH1 responses, inhibits HIV entry, and is implicated in autoimmune disease.

Interleukin-19

Interleukin-19 (IL-19), an IL-10 family cytokine discovered in 2000, produced mainly by monocytes, signaling via the IL-20Rα/IL-20Rβ receptor and STAT3; linked to Th2 responses, asthma, psoriasis, and inflammatory bowel disease.

Interleukin-2 receptor alpha

Interleukin-2 receptor alpha (IL2RA, CD25, TAC antigen, p55) is the IL-2-binding alpha chain of the interleukin-2 receptor; signaling-inert itself, it confers high affinity (Kd ~10-50 pM) on the trimeric receptor, is constitutive on Tregs, and its deficiency causes IPEX-like immunodysregulation.

Interleukin-22

Interleukin-22 (IL-22, formerly IL-TIF) is an IL-10 family cytokine, cloned in 2000, made by Th17/Th22 T cells and ILC3s, signaling via IL-22R1/IL-10R2 to STAT3 in epithelial cells, with tissue-protective and pathogenic roles.

Interleukin-24

Interleukin-24 (IL-24), also called melanoma differentiation associated gene-7 (mda-7), is a cytokine of the interleukin-10 family that suppresses melanoma growth and induces apoptosis in tumor cells while sparing normal cells.

Interleukin-33

Interleukin-33 (IL-33), an IL-1 family alarmin cytokine stored in the nucleus of endothelial and epithelial cells, signals through the ST2/IL-1RAcP receptor and drives type 2 immunity, asthma, and tissue repair.

Interleukin-34

Interleukin-34 (IL-34, C16orf77) is a secreted homodimeric cytokine discovered in 2008 as a second ligand of CSF-1R alongside CSF-1; it sustains monocytes, macrophages, Langerhans cells, and microglia, and is studied as a disease biomarker and drug target.

Interleukin-5

Interleukin-5 (IL-5), also called eosinophil differentiation factor and T-cell replacing factor, is a homodimeric type 2 cytokine regulating eosinophil differentiation, survival, and activation; targeted by mepolizumab, reslizumab, benralizumab, and depemokimab.

Interleukin-9

Interleukin-9 (IL-9, P40, TCGF III, MEA) is a pleiotropic gamma-chain family cytokine produced mainly by Th9 cells; it drives mast cell and type 2 immunity, asthma, parasite responses, and dual roles in cancer.